New chimaeric hepatitis B virus core particles carrying hantavirus (serotype Puumala) epitopes: Immunogenicity and protection against virus challenge

Journal of Biotechnology

Volumn 73, Issue 2-3, 1999, Pages 141-153

  Ulrich, R ^a   Koletzki, D ^a   Lachmann, S ^a   Lundkvist, Å ^b   Zankl, A ^a   Kazaks, A ^c   Kurth, A ^d   Gelderblom, H R ^d   Borisova, G ^c   Meisel, H ^a   Kruger D H ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c UNIVERSITY OF LATVIA   (Latvia)

^d ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Epitopes; Hantavirus; HBV core particles; Mosaic particles; Nucleocapsid protein; Virus like particles

Indexed keywords

AMINO ACIDS; BIOTECHNOLOGY; ESCHERICHIA COLI; IMMUNIZATION; PROTEINS;

EPITOPES; HANTAVIRUS; HEPATITIS B VIRUS CORE PARTICLES; IMMUNOGENECITY; MOSAIC PARTICLES; NUCLEOCAPSID PROTEIN; VIRUS LIKE PARTICLES;

VIRUSES;

EPITOPE; HEPATITIS B CORE ANTIGEN; NUCLEOCAPSID PROTEIN; VIRUS VACCINE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL MODEL; ANTIBODY RESPONSE; CARBOXY TERMINAL SEQUENCE; CHIMERA; CONFERENCE PAPER; ELECTRON MICROSCOPY; ESCHERICHIA COLI; GENE INSERTION SEQUENCE; HANTAVIRUS; HEPATITIS B VIRUS; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PUUMALA VIRUS; SEROTYPE; VIRUS PARTICLE; VOLE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, VIRAL; ARVICOLINAE; BASE SEQUENCE; BIOTECHNOLOGY; EPITOPES; GENETIC VECTORS; HANTAVIRUS; HANTAVIRUS INFECTIONS; HEPATITIS B CORE ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; PLASMIDS; RECOMBINANT FUSION PROTEINS; VACCINES, SYNTHETIC; VIRAL VACCINES;

CLETHRIONOMYS GLAREOLUS; ESCHERICHIA COLI; HANTAVIRUS; HEPATITIS B VIRUS; MURIDAE; PUUMALA VIRUS;

EID: 0344199395     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1656(99)00117-0     Document Type: Conference Paper

References (41)

1. Adams S.E., Burns N.R., Layton G.T., Kingsman A.J. Hybrid Ty virus-like particles. Int. Rev. Immunol. 11:1994;133-141.
2. Berzins I., Ulrich R., Meisel H. et al. Sites in the core antigen of HBV allowing insertion of foreign epitopes. Norrby E., Brown F., Chanock R.M., Ginsberg H.S. Vaccines 94. 1994;301-308 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
3. Birnbaum F., Nassal M. Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein. J. Virol. 64:1990;3319-3330.
4. Böttcher B., Wynne S.A., Crowther R.A. Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy. Nature. 386:1997;88-91.
5. Borisova G.P., Kalis J.V., Pushko P.M. et al. Gene-engineered mutants of hepatitis B virus core antigen which retain ability to functional self-assembly. Dokl. Akad. Nauk SSSR. 298:1988;1474-1478. In Russian.
6. Borisova G.P., Berzins I., Pushko P.M. et al. Recombinant core particles of hepatitis B virus exposing foreign antigenic determinants on their surface. FEBS Lett. 259:1989;121-124.
7. Borisova G., Borschukova Wanst O., Mezule G. et al. Spatial structure and insertion capacity of immunodominant region of hepatitis B core antigen. Intervirology. 39:1996;16-22.
8. Brown A.L., Francis M.J., Hastings G.Z. et al. Foreign epitopes in immunodominant regions of hepatitis B core particles are highly immunogenic and conformationally restricted. Vaccine. 9:1991;595-601.
9. Chu Y.-K., Jennings G.B., Schmaljohn C.S. A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul virus but not Puumala virus. J. Virol. 69:1995;6417-6423.
10. Clarke B.E., Newton S.E., Carroll A.R. et al. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature. 330:1987;381-384.
11. Colucci G., Beazer Y., Castalluppi C., Tackney C. Identification of a major hepatitis B core antigen (HBcAg) determinant by using synthetic peptides and monoclonal antibodies. J. Immunol. 141:1988;4376-4380.
12. Conway J.F., Cheng N., Zlotnick A., Wingfield P.T., Stahl S.J., Steven A.C. Visualization of a 4-helix bundle in the hepatitis B virus capsid by cryo-electron microscopy. Nature. 386:1997;91-94.
13. Gallina A., Bonelli F., Zentilin L., Rindi G., Muttini M., Milanesi G. A recombinant hepatitis B core antigen polypeptide with the protamine-like domain deleted self-assembles into capsid particles but fails to bind nucleic acids. J. Virol. 63:1989;4645-4652.
14. Koletzki D., Zankl A., Gelderblom H.R. et al. Mosaic HBV core particles allow insertion of extended foreign protein segments. J. Gen. Virol. 78:1997;2049-2053.
15. Koletzki D., Biel S.S., Meisel H. et al. HBV core particles allow the insertion and surface exposure of the entire potentially protective region of Puumala hantavirus nucleocapsid protein. Biol. Chem. 380:1999;325-333.
16. Kozlovska T.M., Cielens I., Vasiljeva I. et al. RNA phage Qß coat protein as a carrier for foreign epitopes. Intervirology. 39:1996;9-15.
17. Lachmann S., Meisel H., Muselmann C. et al. Characterization of potential insertion sites in the core antigen of hepatitis B virus by the use of a short-sized model epitope. Intervirology. 42:1999;51-56.
18. Lundkvist Å., Niklasson B. Haemorrhagic fever with renal syndrome and other hantavirus infections. Rev. Med. Virol. 4:1994;177-184.
19. Lundkvist Å., Kallio-Kokko H., Brus Sjölander K. et al. Characterization of Puumala virus nucleocapsid protein: identification of B-cell epitopes and domains involved in protective immunity. Virology. 216:1996;397-406.
20. Lundkvist Å., Hukic M., Hörling J., Gilljam M., Nichol S., Niklasson B. Puumala and Dobrava viruses cause hemorrhagic fever with renal syndrome in Bosnia-Herzegovina: evidence of highly cross-neutralizing antibody responses in early patient sera. J. Med. Virol. 53:1997;51-59.
21. Lundkvist Å, Cheng Y., Brus Sjölander K., Niklasson B., Vaheri A., Plyusnin A. Cell culture adaptation of Puumala hantavirus changes the infectivity for its natural reservoir, Clethrionomys glareolus, and leads to accumulation of mutants with altered genomic RNA S segment. J. Virol. 71:1997;9515-9523.
22. Michel M.-L., Mancini M., Sobczak E. et al. Induction of anti-human immunodeficiency virus (HIV) neutralizing antibodies in rabbits immunized with recombinant HIV-hepatitis B surface antigen particles. Proc. Natl. Acad. Sci. USA. 85:1988;7957-7961.
23. Plyusnin A., Vapalahti O., Vaheri A. Hantaviruses: genome structure, expression and evolution. J. Gen. Virol. 77:1996;2677-2687.
24. Pumpens P., Borisova G.P., Crowther R.A., Grens E. Hepatitis B core particles as epitope carriers. Intervirology. 38:1995;63-74.
25. Pushko P., Sällberg M., Borisova G. et al. Identification of hepatitis B virus core protein regions exposed or internalized at the surface of HBcAg particles by scanning with monoclonal antibodies. Virology. 202:1994;912-920.
26. Reip A., Haring B., Sibold C. et al. Coding strategy of the S and M genomic segments of a hantavirus representing a new subtype of the Puumala serotype. Arch. Virol. 140:1995;2011-2026.
27. Roy P. Genetically engineered particulate virus-like structures and their use as vaccine delivery systems. Intervirology. 39:1996;62-71.
28. Sällberg M., Ruden U., Wahren B., Noah M., Magnius L.O. Human and murine B-cells recognize the HBeAg/beta (or HBe2) epitope as a linear determinant. Mol. Immunol. 28:1991;719-726.
29. Salfeld J., Pfaff E., Noah M., Schaller H. Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus. J. Virol. 63:1989;798-808.
30. Schmaljohn C.S., Chu Y.-K., Schmaljohn A.L., Dalrymple J.M. Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants. J. Virol. 64:1990;3162-3170.
31. Schödel F., Moriarty A.M., Peterson D.L. et al. The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity. J. Virol. 66:1992;106-114.
32. Schödel F., Wirtz R., Peterson D. et al. Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes. J. Exp. Med. 180:1994;1037-1046.
33. Stahl S.J., Murray K. Immunogenicity of peptide fusions to hepatitis B virus core antigen. Proc. Natl. Acad. Sci. USA. 86:1989;6283-6287.
34. Tobin G.J., Nagashima K., Gonda M.A. Synthesis and assembly of chimaeric human immunodeficiency virus gag pseudovirions. Intervirology. 39:1996;40-48.
35. Ulrich R., Borisova G.P., Gren E. et al. Immunogenicity of recombinant core particles of hepatitis B virus containing epitopes of human immunodeficiency virus 1 core antigen. Arch. Virol. 126:1992;321-328.
36. Ulrich R., Gerlich W., Krüger D.H. Chimaera and its modern virus-like descendants. Intervirology. 39:1996;126-132.
37. Ulrich R., Koletzki D., Zankl A. et al. A new strategy to generate mosaic HBcAg particles presenting foreign epitopes. Brown F., Burton D., Doherty P., Mekalanos J., Norrby E. Vaccines 97. 1997;235-240 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
38. Ulrich R., Nassal M., Meisel H., Krüger D.H. Core particles of hepatitis B virus as carrier for foreign epitopes. Adv. Virus Res. 50:1998;141-182.
39. Ulrich R., Lundkvist Å., Meisel H. et al. Chimaeric HBV core particles carrying a defined segment of Puumala hantavirus nucleocapsid protein evoke protective immunity in an animal model. Vaccine. 16:1998;272-280.
40. Wagner R., Deml L., Notka F. et al. Safety and immunogenicity of recombinant human immunodeficiency virus-like particles in rodents and rhesus macaques. Intervirology. 39:1996;93-103.
41. Xu X., Ruo S.L., McCormick J.B., Fisher-Hoch S.P. Immunity to hantavirus challenge in Meriones unguiculatus induced by vaccinia-vectored viral proteins. Am. J. Trop. Med. Hyg. 47:1992;397-404.